Sort
34,240 grants matching “atherosclerosis”
Mitochondrial Modulation of Endothelial Phenotype
$448,177John Francis Keaney · Boston University Medical Campus · P01 · FY2008 · HL
MEDIATORS AND MODIFIERS OF NF-kappaB IN INSULIN RESISTANCE
$448,123Steven E Shoelson · Joslin Diabetes Center · R37 · FY2008 · DK
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
$448,062Kevin D. O'Brien · University Of Washington · R01 · FY2008 · HL
Intergration of Functional and Molecular Genetics to Identify Diabetes Genes
$447,936Donald W. Bowden · Wake Forest University Health Sciences · R01 · FY2008 · DK
Cell Adhesion Molecules in Endothelial Mechanosignaling
$447,750University Of Rochester · R01 · FY2004 · HL
Neuroimaging Measures of Psychosocial Stress as Predictors of Articular and Arterial Inflammation and Treatment Response in Rheumatoid Arthritis
$447,731Jon T Giles · Cedars-Sinai Medical Center · R01 · FY2025 · AR
Lipid Homeostasis, Immunity and Atherosclerosis
$447,682Catherine C Hedrick · La Jolla Institute For Immunology · R01 · FY2015 · HL
Neurobiological pathways linking stress and emotion to atherosclerosis
$447,610Peter J Gianaros · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · HL
Cardioprotective Effects of PDE-5 Inhibitors
$447,575Rakesh C. Kukreja · Virginia Commonwealth University · R01 · FY2011 · HL
Post-DPP Follow-Up Study
$447,503Neil H. White · Washington University · U01 · FY2008 · DK
Total plasma and IgG glycomes, statin therapy and ASCVD events
$447,500Samia Mora · Brigham And Women'S Hospital · R01 · FY2022 · HL
Total plasma and IgG glycomes, statin therapy and ASCVD events
$447,500Samia Mora · Brigham And Women'S Hospital · R01 · FY2021 · HL
Total plasma and IgG glycomes, statin therapy and ASCVD events
$447,500Samia Mora · Brigham And Women'S Hospital · R01 · FY2020 · HL
CCR2 in Atherosclerosis and Leukocyte Trafficking
$447,500J. David Gladstone Institutes · R01 · FY2004 · HL
Fractalkine: Roles in Cell Adhesion and Atherosclerosis
$447,500J. David Gladstone Institutes · R01 · FY2004 · HL
Lipoprotein(a) and Atherosclerosis
$447,500J. David Gladstone Institutes · R01 · FY2004 · HL
Total plasma and IgG glycomes, statin therapy and ASCVD events
$447,500Samia Mora · Brigham And Women'S Hospital · R01 · FY2019 · HL
CCR2 in Atherosclerosis and Leukocyte Trafficking
$447,500J. David Gladstone Institutes · R01 · FY2003 · HL
Novel carbon nanodots for modulation of OxLDL mediated inflammation and inhibition of atherosclerosis
$447,475Zhenquan Jia · University Of North Carolina Greensboro · R15 · FY2020 · HL
SYSTEMIC EFFECTS OF PERIODONTITIS
$447,360University Of North Carolina Chapel Hill · R01 · FY2000 · DE
Mitochondrial Modulation of Endothelial Phenotype
$447,317John F. Keaney · Boston University Medical Campus · P01 · FY2007 · HL
NF-KB, Inflammation and Vascular Remodeling
$447,291Steven E Shoelson · Beth Israel Deaconess Medical Center · P50 · FY2012 · HL
Molecular Regulation of Cardiovascular 7 TM Receptors
$447,284Robert J Lefkowitz · Duke University · R01 · FY2013 · HL
ARTHEROSCLEROSIS IN INSULIN-RESISTANT, HYPERLIPIDEMIC P*
$447,247University Of North Carolina Chapel Hill · R01 · FY2003 · HL
Enhancer of zeste homolog 2-mediated epigenetic activation of acid sphingomyelinase in endothelial dysfunction during obesity
$447,120Xiang Li · University Of Houston · R01 · FY2022 · HL